Singleron Biotechnologies, a Chinese biotechnology start-up providing molecular diagnostic services, announced on Friday that it has raised nearly RMB100 million (US$14.57 million) in a series pre-A round of financing led by Beijing-based Sherpa Venture Capital. Chinese early-stage venture capital company China Growth Capital, and returning investors including Oriza Seed Fund and Frees Fund, also participated […] Chinese Molecular Diagnostic Start-Up Closes $14M Series Pre-A Round comes originally from China Money Network. All Rights Reserved.